{"disease":{"id":"retinitis-pigmentosa-rp","name":"retinitis pigmentosa rp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06092346","title":"A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":999,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT07265895","title":"Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT06982417","title":"InsightRP2 Registry","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Göttingen","has_results":false},{"nct_id":"NCT03975543","title":"Retrospective Natural History Study of Retinitis Pigmentosa","phase":"","overall_status":"UNKNOWN","enrollment_count":113,"lead_sponsor_name":"SparingVision","has_results":false},{"nct_id":"NCT06908161","title":"Functional Assessments in Vision Impairment","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Center for Eye Research Australia","has_results":false},{"nct_id":"NCT06492850","title":"Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":32,"lead_sponsor_name":"Frontera Therapeutics","has_results":false},{"nct_id":"NCT07348588","title":"Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Centro de Pesquisa Rubens Siqueira","has_results":false},{"nct_id":"NCT07341919","title":"Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Rubens Camargo Siqueira","has_results":false},{"nct_id":"NCT07282457","title":"Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":21,"lead_sponsor_name":"Zhongmou Therapeutics","has_results":false},{"nct_id":"NCT07341763","title":"Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"University of Waterloo","has_results":false},{"nct_id":"NCT07174726","title":"A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Beacon Therapeutics","has_results":false},{"nct_id":"NCT07266584","title":"Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration","phase":"NA","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"Science Corporation","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}